Nephros announced its entry into Puerto Rico, targeting high‑need water filtration applications such as ice machines, drinking fountains, bottle fillers and sterile processing environments. The company highlighted a $10 million opportunity in the island market, broken down into $3 million for healthcare, $3 million for foodservice, $1 million for hotels, $1 million for other hospitality, and $1 million for service contracts and replacements.
The expansion reflects Nephros’ broader strategy to move beyond its traditional dialysis and hospital focus into municipal, dental and other commercial verticals. By offering reliable, high‑quality filtration and local‑language support, the company aims to address unmet needs in Puerto Rico’s water‑related infrastructure.
CEO Robert Banks said, “We believe Puerto Rico is a massively underserved market when it comes to reliable, high‑quality filtration—particularly for environments where bacteria and harmful contaminants in water can have serious consequences.” The quote underscores the company’s focus on infection control and water purity in a region with documented water quality challenges.
Nephros’ financial performance has been strong, with revenue growth of 32.4% year‑over‑year and a gross profit margin of 63.2%. The company reported $4.8 million in revenue and $0.3 million in net income for Q3 2025, its fifth consecutive profitable quarter, and maintains a debt‑free balance sheet and healthy cash reserves.
The company recently launched a PFAS filtration solution in October 2025 and established the Nephros Water Institute in December 2025 to advance water safety education. These initiatives reinforce Nephros’ commitment to innovation and market expansion, positioning the firm to capture new revenue streams in Puerto Rico and beyond.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.